(Q44518877)

English

Extremely high levels of von Willebrand factor antigen and of procoagulant factor VIII found in multiple myeloma patients are associated with activity status but not with thalidomide treatment

scientific article published in March 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 December 2017

Extremely high levels of von Willebrand factor antigen and of procoagulant factor VIII found in multiple myeloma patients are associated with activity status but not with thalidomide treatment (English)

1 reference

Europe PubMed Central

3 December 2017

0 references

multiple myeloma

1 reference

based on heuristic

inferred from title

Monique C Minnema

1

object named as

Minnema MC

1 reference

Europe PubMed Central

3 December 2017

Henk M. Lokhorst

4

object named as

Lokhorst HM

1 reference

Europe PubMed Central

3 December 2017

author name string

Fijnheer R

2

1 reference

Europe PubMed Central

3 December 2017

De Groot PG

3

1 reference

Europe PubMed Central

3 December 2017

publication date

1 March 2003

1 reference

Europe PubMed Central

3 December 2017

Journal of Thrombosis and Haemostasis

1 reference

Europe PubMed Central

3 December 2017

1

1 reference

Europe PubMed Central

3 December 2017

3

1 reference

Europe PubMed Central

3 December 2017

445-449

1 reference

Europe PubMed Central

3 December 2017

Antitumor activity of thalidomide in refractory multiple myeloma

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00083.X

21 January 2018

Deep venous thrombosis and thalidomide therapy for multiple myeloma

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00083.X

21 January 2018

Increased risk of deep-vein thrombosis in patients with multiple myeloma receiving thalidomide and chemotherapy.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00083.X

21 January 2018

Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00083.X

21 January 2018

Interleukin 11 significantly increases plasma von Willebrand factor and factor VIII in wild type and von Willebrand disease mouse models

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00083.X

21 January 2018

Safety and efficacy of thalidomide in patients with myelofibrosis with myeloid metaplasia.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00083.X

21 January 2018

Thalidomide produces transfusion independence in long-standing refractory anemias of patients with myelodysplastic syndromes.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00083.X

21 January 2018

Thalidomide in multiple myeloma, myelodysplastic syndromes and histiocytosis. Analysis of clinical results and of surrogate angiogenesis markers

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00083.X

21 January 2018

High Antihaemophilic Factor in Multiple Myeloma

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00083.X

21 January 2018

Identifiers

10.1046/J.1538-7836.2003.00083.X

1 reference

Europe PubMed Central

3 December 2017

release_2vi5yajs2jga7isejcbkyadjfe

1 reference

https://api.fatcat.wiki/v0/release/2vi5yajs2jga7isejcbkyadjfe

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

3 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44518877&oldid=2171868359"